Literature DB >> 20428093

Fanconi anemia and breast cancer susceptibility meet again.

Ephrat Levy-Lahad1.   

Abstract

A new study reports biallelic mutations in RAD51C in a Fanconi anemia-like disorder, while a second study reports monoallelic mutations in the same gene associated with increased breast cancer risk. These findings strengthen the link between Fanconi anemia and breast cancer-associated pathways.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20428093     DOI： 10.1038/ng0510-368

Source DB:  PubMed          Journal:  Nat Genet        ISSN： 1061-4036            Impact factor:   38.330


  15 in total

1.  The DNA helicase BRIP1 is defective in Fanconi anemia complementation group J.

Authors:  Marieke Levitus; Quinten Waisfisz; Barbara C Godthelp; Yne de Vries; Shobbir Hussain; Wouter W Wiegant; Elhaam Elghalbzouri-Maghrani; Jûrgen Steltenpool; Martin A Rooimans; Gerard Pals; Fré Arwert; Christopher G Mathew; Małgorzata Z Zdzienicka; Kevin Hiom; Johan P De Winter; Hans Joenje
Journal:  Nat Genet       Date:  2005-08-21       Impact factor: 38.330

2.  Fanconi anemia is associated with a defect in the BRCA2 partner PALB2.

Authors:  Bing Xia; Josephine C Dorsman; Najim Ameziane; Yne de Vries; Martin A Rooimans; Qing Sheng; Gerard Pals; Abdellatif Errami; Eliane Gluckman; Julian Llera; Weidong Wang; David M Livingston; Hans Joenje; Johan P de Winter
Journal:  Nat Genet       Date:  2006-12-31       Impact factor: 38.330

3.  Fanconi anemia and breast cancer susceptibility.

Authors:  Ketan J Patel
Journal:  Nat Genet       Date:  2007-02       Impact factor: 38.330

4.  Clinical and molecular features associated with biallelic mutations in FANCD1/BRCA2.

Authors:  Blanche P Alter; Philip S Rosenberg; Lawrence C Brody
Journal:  J Med Genet       Date:  2006-07-06       Impact factor: 6.318

5.  Mutation of the RAD51C gene in a Fanconi anemia-like disorder.

Authors:  Fiona Vaz; Helmut Hanenberg; Beatrice Schuster; Karen Barker; Constanze Wiek; Verena Erven; Kornelia Neveling; Daniela Endt; Ian Kesterton; Flavia Autore; Franca Fraternali; Marcel Freund; Linda Hartmann; David Grimwade; Roland G Roberts; Heiner Schaal; Shehla Mohammed; Nazneen Rahman; Detlev Schindler; Christopher G Mathew
Journal:  Nat Genet       Date:  2010-04-18       Impact factor: 38.330

6.  Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene.

Authors:  Alfons Meindl; Heide Hellebrand; Constanze Wiek; Verena Erven; Barbara Wappenschmidt; Dieter Niederacher; Marcel Freund; Peter Lichtner; Linda Hartmann; Heiner Schaal; Juliane Ramser; Ellen Honisch; Christian Kubisch; Hans E Wichmann; Karin Kast; Helmut Deissler; Christoph Engel; Bertram Müller-Myhsok; Kornelia Neveling; Marion Kiechle; Christopher G Mathew; Detlev Schindler; Rita K Schmutzler; Helmut Hanenberg
Journal:  Nat Genet       Date:  2010-04-18       Impact factor: 38.330

Review 7.  How the fanconi anemia pathway guards the genome.

Authors:  George-Lucian Moldovan; Alan D D'Andrea
Journal:  Annu Rev Genet       Date:  2009       Impact factor: 16.830

8.  PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene.

Authors:  Nazneen Rahman; Sheila Seal; Deborah Thompson; Patrick Kelly; Anthony Renwick; Anna Elliott; Sarah Reid; Katarina Spanova; Rita Barfoot; Tasnim Chagtai; Hiran Jayatilake; Lesley McGuffog; Sandra Hanks; D Gareth Evans; Diana Eccles; Douglas F Easton; Michael R Stratton
Journal:  Nat Genet       Date:  2006-12-31       Impact factor: 38.330

9.  RAD51C facilitates checkpoint signaling by promoting CHK2 phosphorylation.

Authors:  Sophie Badie; Chunyan Liao; Maria Thanasoula; Paul Barber; Mark A Hill; Madalena Tarsounas
Journal:  J Cell Biol       Date:  2009-05-18       Impact factor: 10.539

10.  The Fanconi anemia pathway promotes replication-dependent DNA interstrand cross-link repair.

Authors:  Puck Knipscheer; Markus Räschle; Agata Smogorzewska; Milica Enoiu; The Vinh Ho; Orlando D Schärer; Stephen J Elledge; Johannes C Walter
Journal:  Science       Date:  2009-11-12       Impact factor: 47.728
View more
  24 in total

1.  The tumour suppressor C/EBPδ inhibits FBXW7 expression and promotes mammary tumour metastasis.

Authors:  Kuppusamy Balamurugan; Ju-Ming Wang; Hsin-Hwa Tsai; Shikha Sharan; Miriam Anver; Robert Leighty; Esta Sterneck
Journal:  EMBO J       Date:  2010-11-12       Impact factor: 11.598

2.  The CHK1 Inhibitor Prexasertib Exhibits Monotherapy Activity in High-Grade Serous Ovarian Cancer Models and Sensitizes to PARP Inhibition.

Authors:  Kalindi Parmar; Bose S Kochupurakkal; Jean-Bernard Lazaro; Zhigang C Wang; Sangeetha Palakurthi; Paul T Kirschmeier; Chunyu Yang; Larissa A Sambel; Anniina Färkkilä; Elizaveta Reznichenko; Hunter D Reavis; Connor E Dunn; Lee Zou; Khanh T Do; Panagiotis A Konstantinopoulos; Ursula A Matulonis; Joyce F Liu; Alan D D'Andrea; Geoffrey I Shapiro
Journal:  Clin Cancer Res       Date:  2019-08-13       Impact factor: 12.531

3.  Human RAD52 - a novel player in DNA repair in cancer and immunodeficiency.

Authors:  Sujal Ghosh; Andrea Hönscheid; Gregor Dückers; Sebastian Ginzel; Holger Gohlke; Michael Gombert; Bettina Kempkes; Wolfram Klapper; Michaela Kuhlen; Hans-Jürgen Laws; René Martin Linka; Roland Meisel; Christian Mielke; Tim Niehues; Detlev Schindler; Dominik Schneider; Friedhelm R Schuster; Carsten Speckmann; Arndt Borkhardt
Journal:  Haematologica       Date:  2016-12-15       Impact factor: 9.941

4.  Mutations in ERCC4, encoding the DNA-repair endonuclease XPF, cause Fanconi anemia.

Authors:  Massimo Bogliolo; Beatrice Schuster; Chantal Stoepker; Burak Derkunt; Yan Su; Anja Raams; Juan P Trujillo; Jordi Minguillón; María J Ramírez; Roser Pujol; José A Casado; Rocío Baños; Paula Rio; Kerstin Knies; Sheila Zúñiga; Javier Benítez; Juan A Bueren; Nicolaas G J Jaspers; Orlando D Schärer; Johan P de Winter; Detlev Schindler; Jordi Surrallés
Journal:  Am J Hum Genet       Date:  2013-04-25       Impact factor: 11.025

Review 5.  Phenotype-genotype correlation in familial breast cancer.

Authors:  Ana Cristina Vargas; Jorge S Reis-Filho; Sunil R Lakhani
Journal:  J Mammary Gland Biol Neoplasia       Date:  2011-03-12       Impact factor: 2.673

Review 6.  RAD51C: a novel cancer susceptibility gene is linked to Fanconi anemia and breast cancer.

Authors:  Kumar Somyajit; Shreelakshmi Subramanya; Ganesh Nagaraju
Journal:  Carcinogenesis       Date:  2010-10-15       Impact factor: 4.944

Review 7.  TNF-α signaling in Fanconi anemia.

Authors:  Wei Du; Ozlem Erden; Qishen Pang
Journal:  Blood Cells Mol Dis       Date:  2013-07-24       Impact factor: 3.039

8.  The HsRAD51B-HsRAD51C stabilizes the HsRAD51 nucleoprotein filament.

Authors:  Ravindra Amunugama; Joanna Groden; Richard Fishel
Journal:  DNA Repair (Amst)       Date:  2013-06-28

Review 9.  Emerging roles of Jab1/CSN5 in DNA damage response, DNA repair, and cancer.

Authors:  Yunbao Pan; Huiling Yang; Francois X Claret
Journal:  Cancer Biol Ther       Date:  2014-02-04       Impact factor: 4.742

Review 10.  Novel insights into RAD51 activity and regulation during homologous recombination and DNA replication.

Authors:  Stephen K Godin; Meghan R Sullivan; Kara A Bernstein
Journal:  Biochem Cell Biol       Date:  2016-03-31       Impact factor: 3.626
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.